Drugs / Lactate
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01919918 | Sep 2013 → Jan 2018 | heart failure | University of Utah | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT06168175 | Jan 2024 → Jan 2028 expected | major depressive disorder | Centre Hospitalier Universitaire Vaudois | Not yet recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01387477 | Jun 2011 → Jun 2012 | hypoglycemia | Institut d'Anesthesiologie des Alpes Maritimes | Withdrawn | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06955130 | Jul 2026 → Apr 2029 expected | obesity disorder, type 2 diabetes mellitus | Rutgers, The State University of New Jersey | Not yet recruiting | No outcome recorded |
| — | NCT03730909 | Jun 2018 → Apr 2019 | type 1 diabetes mellitus | Radboud University Medical Center | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT06825143 Comparator | Oct 2026 → Sep 2029 expected | metabolic syndrome X, vascular insufficiency disorder | Gary Van Guilder | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT04858139 Comparator | Aug 2021 → Mar 2025 | ischemic stroke | Centre Hospitalier Universitaire Vaudois | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lactate | “adenosine triphosphate, lactate, and protons with phosphate buffer” NCT01919918 ↗ |
| Route | Intravenous | “IV infusion” NCT03730909 ↗ |